Regional
Region X EMS
Region X EMS (IL) carries 25 drugs across 91 dose entries in its current published protocol, effective 2026-05-25.
An undated version is under review. The figures below are from the current listed document.
Drugs and doses25
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 20 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 81 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2.5 mg | NEB | not captured | standing | page 36 |
| Allergic reaction | peds | 2.5 mg | NEB | not captured | standing | page 36 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 30 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 30 |
| Crush injury | adult | 2.5 mg | NEB | not captured | standing | page 59 |
| Crush injury | peds | 2.5 mg | NEB | not captured | standing | page 59 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 81 |
| Wide-complex tachycardia | adult | 150 mg | not captured | not captured | standing | page 21 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 24 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 16 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 43 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 44 |
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 18 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 18 |
| Organophosphate poisoning | adult | See table | IM | not captured | standing | page 41 |
| Organophosphate poisoning | peds | See table | IM | not captured | standing | page 41 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25 g | IV/IO | not captured | standing | page 38 |
| Other | peds | 0.5 g/kg | IV/IO | not captured | standing | page 38 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25 mg | IV | not captured | standing | page 36 |
| Allergic reaction | adult | 25 mg | IM | not captured | standing | page 36 |
| Allergic reaction | adult | 50 mg | IV/IO | not captured | standing | page 36 |
| Allergic reaction | adult | 50 mg | IM | not captured | standing | page 36 |
| Allergic reaction | peds | 1 mg/kg | IV/IO | not captured | standing | page 36 |
| Allergic reaction | peds | 1 mg/kg | IM | not captured | standing | page 36 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | page 36 |
| Allergic reaction | peds | 1 mg/kg | IM | not captured | standing | page 36 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3 mg | IM | not captured | standing | page 36 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 30 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 86 |
| Asystole / PEA | adult | 1 mg | IV/IO | not captured | standing | page 23 |
| Asystole / PEA | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 83 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 79 |
| Cardiogenic shock | peds | 1 mcg/kg | IV/IO | not captured | standing | page 80 |
| VF / pulseless VT | adult | 1 mg | IV/IO | not captured | standing | page 24 |
| VF / pulseless VT | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 84 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 134 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 134 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 16 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 16 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 43 |
| Other | adult | 1 mg | IM/IN | not captured | standing | page 38 |
| Other | peds | 0.5 mg | IM/IN | not captured | standing | page 38 |
Hydralazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV/IO | not captured | standing | page 78 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | page 36 |
| Allergic reaction | peds | 0.5 mg | NEB | not captured | standing | page 36 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 30 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 30 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | See ideal body weight chart | IM | not captured | standing | page 14 |
| Agitation | peds | 4 mg/kg | IM | not captured | standing | page 14 |
| RSI induction | adult | See ideal body weight chart | IV/IO | not captured | standing | page 33 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 88 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IO | not captured | standing | page 143 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 143 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | not captured | not captured | standing | page 30 |
| Asthma / bronchospasm | peds | 25 mg/kg | not captured | not captured | standing | page 86 |
| Wide-complex tachycardia | adult | 2 g | not captured | not captured | standing | page 21 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 2 mg | IV/IO | not captured | standing | page 17 |
| Agitation | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 14 |
| Bradycardia | adult | 2 mg | IV/IO | not captured | standing | page 18 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 49 |
| Seizure | adult | 2 mg | IV/IO/IN | not captured | standing | page 49 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 49 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IN | not captured | standing | page 49 |
| SVT | adult | 2 mg | IV/IO | not captured | standing | page 20 |
| Narrow-complex tachycardia | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 81 |
| Wide-complex tachycardia | adult | 2 mg | IV/IO | not captured | standing | page 21 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2 mg | IM/IN | not captured | standing | page 45 |
| Respiratory distress | adult | 2 mg | IV/IO | not captured | standing | page 45 |
| Respiratory distress | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 45 |
| Respiratory distress | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 45 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 16 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 32 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 40 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 96 |
| Other | adult | 4 mg | IV | not captured | standing | page 46 |
| Mild to moderate pain | adult | 4 mg | IV/IO | not captured | standing | page 48 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 98 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 g | PO | not captured | standing | page 38 |
| Other | peds | 15 g | PO | not captured | standing | page 38 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | page 41 |
| Organophosphate poisoning | peds | 15 mg/kg | IM | not captured | standing | page 41 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asystole / PEA | adult | 50 mEq | IV/IO | not captured | standing | page 23 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 50 mEq | IV/IO | not captured | standing | page 43 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 59 |
| VF / pulseless VT | adult | 50 mEq | IV/IO | not captured | standing | page 24 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 77 |
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 63 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5 mg | IV | not captured | standing | page 17 |
| SVT | adult | 5 mg | IV | not captured | standing | page 20 |